22 May 2013
Keywords: approval, market, merck, co, comvax, received, food
Article | 14 October 1996
- Merck & Co has received US Food and Drug Administration approval to
market Comvax (combined PedvaxHIB for Hemophilus infuenzae type b
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
14 October 1996
21 May 2013
© 2013 thepharmaletter.com